AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports - Reuters

Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports - Reuters

Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports Reuters

July 15, 2026 at 11:30 PM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

Germany USA

Tags

acquisition atai beckley eli lilly mergers and acquisitions pharmaceuticals psychedelic drugs

All Coverage

Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxQUkdBem1IX3AtekZzbllhUEZyTU9HQU1RY1AxRF9ZSnNoNlAybXNmcnFnTDZ3X3RJWDQ4bXNlNERLeWlUNy02dFNfQl9BbXBKZmRHVXRpdi1oMXltUF9qNVB2NEQ0WDJJbmdXSDJ6WGJDUzR2c0t6MDVycnhKOWRCckwySkc1SjN6d1FZNWpzZW5nSnRHRWl4M3dtaXNMeGN1d0RuMVJsTjR1R25EYWhsbmR5Rk9ndzdhTzJuVzN4QUg2SFR5cDZPbUxDVHhjVmhWaDlaTGI0Z1NwTUhGTlE?oc=5" target="_blank">Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%

Similar Stories

Related coverage based on topic and tags

Novo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com

Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com

August 13, 2026 at 10:02 AM

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com

August 12, 2026 at 10:27 AM

As Hims prepares for peptides launch, Wall Street cautious on prospects this year - Reuters

As Hims prepares for peptides launch, Wall Street cautious on prospects this year Reuters

August 12, 2026 at 06:34 PM

EyePoint's drug for age-related eye disease fails late-stage trial, shares tank - Reuters

EyePoint's drug for age-related eye disease fails late-stage trial, shares tank Reuters

August 17, 2026 at 03:45 PM

Lawsuit against Bristol Myers over delayed cancer drug is revived - Reuters

Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters

August 13, 2026 at 06:00 PM

Humana agrees not to reference Teva's Israel ties at US drug trial - Reuters

Humana agrees not to reference Teva's Israel ties at US drug trial Reuters

August 13, 2026 at 03:33 PM